
ML Strategies
Viewpoints
Filter by:
A Continued Examination of Charitable Patient Assistance Programs: Part Eight in a Series: What Products Say About Charitable PAPs
September 16, 2013 | Alert | By Joseph Hammang, Alexander Hecht
In today’s challenging health care environment, Charitable Patient Assistance Programs (Charitable PAPs) have emerged to meet the needs of nearly 30 million Americans that are underinsured and have difficulty paying out-of-pocket medical costs.
Read more
A Continued Examination of Charitable Patient Assistance Programs- Part Seven in a Series: Charitable PAPs: Donations and Transparency
August 28, 2013 | Alert | By Joseph Hammang, Alexander Hecht
In today’s challenging health care environment, Charitable Patient Assistance Programs (Charitable PAPs) have emerged to meet the needs of the nearly 30 million Americans that are underinsured and have difficulty paying out-of-pocket medical costs.
Read more
A Continued Examination of Charitable Patient Assistance Programs Part Six in a Series: What the Scope of Services Says About a Charitable PAP
August 15, 2013 | Advisory | By Alexander Hecht, Joseph Hammang
In today’s challenging health care environment, Charitable Patient Assistance Programs (Charitable P.A.P.s) have emerged to meet the needs of the nearly 30 million Americans who are underinsured and have difficulty paying out-of-pocket medical costs.
Read more
A Continued Examination of Charitable Patient Assistance Programs Part Four in a Series: Staying True to the Definition of an Independent, Nonprofit Charitable PAP
July 25, 2013 | Alert | By Joseph Hammang, Alexander Hecht
In today’s challenging health care environment, Charitable Patient Assistance Programs (Charitable PAPs) have emerged to meet the needs of the nearly 30 million Americans who are underinsured and have difficulty paying out-of-pocket medical costs.
Read more
Examining Charitable Patient Assistance Programs Part Three in a Series: Using Third Parties to Evaluate Charitable PAPs
July 11, 2013 | Alert | By Joseph Hammang, Alexander Hecht
In today’s challenging health care environment, Charitable Patient Assistance Programs (Charitable PAPs) have emerged to meet the needs of the nearly 30 million Americans that are under-insured and have difficulty paying out-of-pocket medical costs.
Read more
Examining Charitable Patient Assistance Programs: Careful Due Diligence Yields Responsible Investment Decisions
June 13, 2013 | Alert | By Joseph Hammang, Alexander Hecht
In today’s challenging health care environment, nearly 30 million Americans suffering from various chronic and life-threatening illnesses are underinsured and have difficulty paying their out-of-pocket medical costs.
Read more
President’s 2014 Budget Proposal for the Department of Health and Human Services (HHS)
April 12, 2013 | Advisory | By Stephen Weiner, Alexander Hecht, Joseph Hammang
The Obama Administration released its proposed Fiscal Year 2014 budget on April 10th. The 244-page document outlines the President’s spending priorities for the coming fiscal year.
Read more
Hints of Bipartisan Cooperation on Health Issues in the Energy & Commerce Committee
January 28, 2013 | Advisory | By Alexander Hecht, Joseph Hammang, Gary Bacher, Tom Koutsoumpas, Jeremy Rabinovitz, Kevin Kappel, Robert Skinner
In first days of 113th Congress, the House approved bipartisan legislation, hinting at possible increased cooperation on health care issues
Read more
Supreme Court Will Not Hear Stem Cell Funding Petition
January 11, 2013 | Advisory | By Joseph Hammang, Alexander Hecht, Robert Skinner
The on again, off again nature of federal funding for human embryonic stem cell (hESC) research has created a great deal of uncertainty for academic scientists, major research medical centers, venture capital investors, biotechnology companies, and state legislatures and economic development officials.
Read more
Massachusetts 2013 – 2014 Legislative Session Preview
January 10, 2013 | Alert | By George Atanasov, Julie Cox
The 188th Massachusetts Legislature began the 2013 – 2014 legislative session on January 2. This alert identifies the key public policy issues that will likely emerge in the current session and offers insight into their possible implications.
Read more
Explore Other Viewpoints:
- Data Centers & Digital Infrastructure
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- DEI Legal Developments
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- EnforceMintz
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Sustainable Energy & Infrastructure
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Unified Patent Court (UPC)
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology